Skip to main content
SpringerLink
Log in

No effect of human chorionic gonadotropin treatment due to threatened abortion in early pregnancy for birth outcomes

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

Human chorionic gonadotropin (HCG) is used parenterally for treatment of threatened abortions and repeated spontaneous abortion in pregnant women. No controlled epidemiological studies of preterm birth and low birthweight newborns in pregnant women with HCG treatment have been published while the results of animal investigations were controversial. The data of 97 pregnant women with HCG treatment in the second and third months of pregnancy due to threatened abortion and/or previous spontaneous abortion(s) was compared with the data of other 38,054 pregnant women in the population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities. There was no difference in mean gestational age at delivery and birth weight, in addition the rate of preterm birth and low birthweight newborns. Parenteral HCG treatment in the early pregnancy due to threatened abortion did not associate with a higher risk for preterm births or low birthweight newborns. However, a higher occurrence of gestational diabetes was found in pregnant women with HCG treatment and there was a slight male excess among newborn infants (p=0.06).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Conlson C.J., Molecular mechanism of drug action. Taylor and Francis, London. 1988

    Google Scholar 

  2. Sakai N., Endo A., Potential teratogenicity of gonadotropin treatment for ovulation induction in the mouse offspring. Teratology, 1987, 36, 229–233

    Article  PubMed  CAS  Google Scholar 

  3. Bussi R., Ciampolillo C., Commotto L., Komatsu S., Maraschin R., Reproductive and developmental toxicity studies of SJ-0021 (v-hFSH). Yakuri to Chiryo., 1995, 23, 1953–1997 cit. Shepard TH, and Lemire RJ, 2004.

    CAS  Google Scholar 

  4. Hultquist G.T., Engfeldt B., Growth of rat fetuses produced experimentally by means of administration of hormones to the mother during pregnancy. Acta Endocrinol (Kbh), 1949, 3, 365–376

    CAS  Google Scholar 

  5. Hack M., Brish M., Serr D., Insler V., Lunenfeld B., Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after gonadotropin therapy. J.A.M.A., 1970, 211, 791–793

    Article  PubMed  CAS  Google Scholar 

  6. Ben-Rafael Z., Mashiach S., Velsner G., Farine D., Lunenfeld B., Serr D.M., Spontaneous pregnancy and its outcome after human menopausal gonadotropin/human chorionic gonadotropin-induced pregnancy. Fertil. Steril., 1981, 36, 560–566

    PubMed  CAS  Google Scholar 

  7. Ben-Rafael Z., Dor J., Mashiach S., Blankstein J., Lunenfeld B., Serr D.M., Abortion rate in pregnancies following ovulation induced by human menopausal gonadotropin/human chorionic gonadotropin. Fertil. Steril., 1983, 39, 157–162

    PubMed  CAS  Google Scholar 

  8. Caspi E., Ronen J., Schreyer P., Goldberg M.D., The outcome of pregnancy after gonadotrophin therapy. Br. J. Obstet. Gynecol., 1996, 83, 967–973

    Google Scholar 

  9. Shepard T.H., Lemire R.J., Catalog of Teratogenic Agents. 11th ed. John Hopkins. Univ. Press, Baltimore, 2004

    Google Scholar 

  10. Czeizel A.E., Rockenbauer M., Siffel Cs., Varga E., Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology, 2001, 63, 176–185

    Article  PubMed  CAS  Google Scholar 

  11. Czeizel A.E., The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology, 1997, 55, 299–305

    Article  PubMed  CAS  Google Scholar 

  12. Czeizel A.E., Petik D., Vargha P., Validation studies of drug exposures in pregnant women. Pharmacoepidemiol. Drug Safety, 2003, 12, 409–406

    Article  CAS  Google Scholar 

  13. Czeizel A.E., Petik D., Puho E., Smoking and alcohol drinking during pregnancy: the validity of retrospective maternal self-reported information. Cent. Eur. J. Publ. Hlth., 2004, 12, 179–193

    CAS  Google Scholar 

  14. Czeizel A.E., Puhó E., Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down’s syndrome: casecontrol study. Nutrition, 2005, 21, 698–704

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Foundation for the Community Control of Hereditary Diseases, 3H-1148, Budapest, Hungary

    Andrew E. Czeizel, István Dudás, János Gidai & Erzsébet Horváth-Puhó

Authors
  1. Andrew E. Czeizel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. István Dudás
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. János Gidai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Erzsébet Horváth-Puhó
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew E. Czeizel.

About this article

Cite this article

Czeizel, A.E., Dudás, I., Gidai, J. et al. No effect of human chorionic gonadotropin treatment due to threatened abortion in early pregnancy for birth outcomes. cent.eur.j.med 3, 71–76 (2008). https://doi.org/10.2478/s11536-007-0056-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-007-0056-9

Keywords

Search

Navigation